Literature DB >> 23371384

Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.

Heather J Baer1, Louise I Schneider, Graham A Colditz, Hank Dart, Analisa Andry, Deborah H Williams, E John Orav, Jennifer S Haas, George Getty, Elizabeth Whittemore, David W Bates.   

Abstract

BACKGROUND: Primary care clinicians can play an important role in identifying individuals at increased risk of cancer, but often do not obtain detailed information on family history or lifestyle factors from their patients.
OBJECTIVE: We evaluated the feasibility and effectiveness of using a web-based risk appraisal tool in the primary care setting.
DESIGN: Five primary care practices within an academic care network were assigned to the intervention or control group. PARTICIPANTS: We included 15,495 patients who had a new patient visit or annual exam during an 8-month period in 2010-2011. INTERVENTION: Intervention patients were asked to complete a web-based risk appraisal tool on a laptop computer immediately before their visit. Information on family history of cancer was sent to their electronic health record (EHR) for clinicians to view; if accepted, it populated coded fields and could trigger clinician reminders about colon and breast cancer screening. MAIN MEASURES: The main outcome measure was new documentation of a positive family history of cancer in coded EHR fields. Secondary outcomes included clinician reminders about screening and discussion of family history, lifestyle factors, and screening. KEY
RESULTS: Among eligible intervention patients, 2.0% had new information on family history of cancer entered in the EHR within 30 days after the visit, compared to 0.6% of eligible control patients (adjusted odds ratio = 4.3, p = 0.03). There were no significant differences in the percent of patients who received moderate or high risk reminders for colon or breast cancer screening.
CONCLUSIONS: Use of this tool was associated with increased documentation of family history of cancer in the EHR, although the percentage of patients with new family history information was low in both groups. Further research is needed to determine how risk appraisal tools can be integrated with workflow and how they affect screening and health behaviors.

Entities:  

Mesh:

Year:  2013        PMID: 23371384      PMCID: PMC3663959          DOI: 10.1007/s11606-013-2338-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  29 in total

Review 1.  Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy approaches.

Authors:  Graham A Colditz; Michelle Samplin-Salgado; Catherine Tomeo Ryan; Hank Dart; Laurie Fisher; Angela Tokuda; Beverly Rockhill
Journal:  Cancer Causes Control       Date:  2002-04       Impact factor: 2.506

2.  Primary care: is there enough time for prevention?

Authors:  Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

3.  PrimeScreen, a brief dietary screening tool: reproducibility and comparability with both a longer food frequency questionnaire and biomarkers.

Authors:  S L Rifas-Shiman; W C Willett; R Lobb; J Kotch; C Dart; M W Gillman
Journal:  Public Health Nutr       Date:  2001-04       Impact factor: 4.022

4.  Identification and referral of families at high risk for cancer susceptibility.

Authors:  Kevin M Sweet; Terry L Bradley; Judith A Westman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

5.  Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention.

Authors:  G A Colditz; K A Atwood; K Emmons; R R Monson; W C Willett; D Trichopoulos; D J Hunter
Journal:  Cancer Causes Control       Date:  2000-07       Impact factor: 2.506

6.  Supporting patient care beyond the clinical encounter: three informatics innovations from partners health care.

Authors:  Eric G Poon; Jonathan Wald; David W Bates; Blackford Middleton; Gilad J Kuperman; Tejal K Gandhi
Journal:  AMIA Annu Symp Proc       Date:  2003

7.  Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk.

Authors:  Daniel J Kim; Beverly Rockhill; Graham A Colditz
Journal:  J Clin Epidemiol       Date:  2004-04       Impact factor: 6.437

Review 8.  Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.

Authors:  Susan A Sabatino; Nancy Habarta; Roy C Baron; Ralph J Coates; Barbara K Rimer; Jon Kerner; Steven S Coughlin; Geetika P Kalra; Sajal Chattopadhyay
Journal:  Am J Prev Med       Date:  2008-07       Impact factor: 5.043

9.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

10.  Can family history be used as a tool for public health and preventive medicine?

Authors:  Paula W Yoon; Maren T Scheuner; Kris L Peterson-Oehlke; Marta Gwinn; Andrew Faucett; Muin J Khoury
Journal:  Genet Med       Date:  2002 Jul-Aug       Impact factor: 8.822

View more
  16 in total

1.  Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.

Authors:  Flore Laforest; Pia Kirkegaard; Baljinder Mann; Adrian Edwards
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

2.  A randomized, controlled trial to increase discussion of breast cancer in primary care.

Authors:  Celia P Kaplan; Jennifer Livaudais-Toman; Jeffrey A Tice; Karla Kerlikowske; Steven E Gregorich; Eliseo J Pérez-Stable; Rena J Pasick; Alice Chen; Jessica Quinn; Leah S Karliner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-24       Impact factor: 4.254

Review 3.  Using e-technologies in clinical trials.

Authors:  Carmen Rosa; Aimee N C Campbell; Gloria M Miele; Meg Brunner; Erin L Winstanley
Journal:  Contemp Clin Trials       Date:  2015-07-12       Impact factor: 2.226

Review 4.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

5.  General internal medicine as an engine of innovation.

Authors:  Richard L Kravitz; Mitchell D Feldman
Journal:  J Gen Intern Med       Date:  2013-06       Impact factor: 5.128

6.  Design and rationale of the STRIVE trial to improve cardiometabolic health among children and families.

Authors:  Nicolas M Oreskovic; Richard Fletcher; Mona Sharifi; John D Knutsen; Ani Chilingirian; Elsie M Taveras
Journal:  Contemp Clin Trials       Date:  2016-07-11       Impact factor: 2.226

Review 7.  The effects of on-screen, point of care computer reminders on processes and outcomes of care.

Authors:  Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Effect of genetics clinical decision support tools on health-care providers' decision making: a mixed-methods systematic review.

Authors:  Agnes Sebastian; June C Carroll; Leslie E Oldfield; Chloe Mighton; Salma Shickh; Elizabeth Uleryk; Yvonne Bombard
Journal:  Genet Med       Date:  2021-01-08       Impact factor: 8.822

9.  Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success.

Authors:  Erika A Waters; Jennifer M Taber; Amy McQueen; Ashley J Housten; Jamie L Studts; Laura D Scherer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-12       Impact factor: 4.254

10.  Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.

Authors:  Xuan Li; Ryan M Kahn; Noelani Wing; Zhen Ni Zhou; Andreas Ian Lackner; Hannah Krinsky; Nora Badiner; Rhea Fogla; Isabel Wolfe; Hannah Bergeron; Becky Baltich Nelson; Charlene Thomas; Paul J Christos; Ravi N Sharaf; Evelyn Cantillo; Kevin Holcomb; Eloise Chapman-Davis; Melissa K Frey
Journal:  JCO Clin Cancer Inform       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.